Larimar Therapeutics, Inc. current report, 12 May 2021

Larimar Therapeutics, Inc. 8-K Summary

Business Context and Reporting Period

This Form 8-K reports on the results of the 2021 Annual Meeting of Stockholders held virtually on May 12, 2021. The record date for the meeting was April 1, 2021, with 15,367,730 outstanding shares of common stock entitled to vote.

Key Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.

Material Changes and Voting Results

Three proposals were submitted to stockholders. The results were as follows:

  • Proposal 1 (Election of Class I Directors): Both Jonathan Leff and Peter Barrett, Ph.D. were elected to the Board of Directors to serve until the 2024 Annual Meeting.
    • Jonathan Leff: 9,119,247 votes For; 2,479,981 votes Against; 1,199 Abstentions; 2,165,475 Broker Non-Votes.
    • Peter Barrett, Ph.D.: 9,143,849 votes For; 2,455,379 votes Against; 1,199 Abstentions; 2,165,475 Broker Non-Votes.
  • Proposal 2 (Advisory Executive Compensation): Stockholders approved the 2020 compensation of named executive officers.
    • 11,569,538 votes For; 29,764 votes Against; 1,125 Abstentions; 2,165,475 Broker Non-Votes.
  • Proposal 3 (Ratification of Auditors): The appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the 2021 fiscal year was ratified.
    • 13,762,719 votes For; 2,299 votes Against; 884 Abstentions; N/A Broker Non-Votes.

Guidance, Outlook, and Risks

The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items beyond the standard disclosure of voting results.

Key Facts for Investor Verification

  • Verify the tenure of the newly elected directors (Jonathan Leff and Peter Barrett) through the 2024 Annual Meeting.
  • Note the significant number of broker non-votes (2,165,475) across all proposals, indicating shares held by brokers that were not voted on discretionary matters.
  • Confirm the ratification of PricewaterhouseCoopers LLP as the auditor for the 2021 fiscal year.
  • Review the definitive proxy statement filed on April 14, 2021, for detailed descriptions of the proposals and executive compensation specifics.